Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1367 |
|
| Actual shortage: | 56 (4%) | |
| Anticipated shortage: | 6 (0%) | |
| Avoided shortage: | 37 (3%) | |
| Resolved: | 1268 (93%) | |
Discontinuation Reports |
291 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 287 (99%) | |
| Reversed: | 2 (1%) | |
Late reports |
211 (13%) |
|
Overdue reports |
8 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-NIFEDIPINE ER | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-02-06 | 2018-09-19 | 38875 |
| PMS-NIFEDIPINE ER | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-10-19 | 2019-11-15 | 64823 |
| PMS-NIFEDIPINE ER | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-01-16 | 2019-06-29 | 72629 |
| PMS-NIFEDIPINE ER | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-01-16 | 2021-10-15 | 72632 |
| PMS-NIFEDIPINE ER | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-03-04 | 2019-09-12 | 77490 |
| PMS-NIFEDIPINE ER | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-09-12 | 2021-10-15 | 93825 |
| PMS-NIFEDIPINE ER | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-11-15 | 2021-10-15 | 98823 |
| PMS-NIFEDIPINE ER | 30MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-11-11 | 2023-02-07 | 174393 |
| PMS-NITROFURANTOIN BID | 100MG | CAPSULE | Resolved | 2018-10-03 | 2019-03-19 | 63129 |
| PMS-NITROFURANTOIN BID | 100MG | CAPSULE | Resolved | 2023-07-13 | 2023-09-15 | 198483 |
| PMS-NITROFURANTOIN BID | 100MG | CAPSULE | Resolved | 2023-12-27 | 2024-02-28 | 214346 |
| PMS-NITROFURANTOIN BID | 100MG | CAPSULE | Resolved | 2024-03-15 | 2024-03-19 | 222381 |
| PMS-NITROFURANTOIN BID | 100MG | CAPSULE | Resolved | 2024-08-05 | 2025-03-07 | 234611 |
| PMS-NYSTATIN SUSPENSION 100000 UNIT/ML | 100000UNIT | SUSPENSION | Resolved | 2017-06-16 | 2017-12-18 | 13118 |
| PMS-NYSTATIN SUSPENSION 100000 UNIT/ML | 100000UNIT | SUSPENSION | Resolved | 2017-07-25 | 2018-05-05 | 17063 |
| PMS-NYSTATIN SUSPENSION 100000 UNIT/ML | 100000UNIT | SUSPENSION | Resolved | 2017-09-19 | 2018-11-29 | 22795 |
| PMS-NYSTATIN SUSPENSION 100000 UNIT/ML | 100000UNIT | SUSPENSION | Resolved | 2017-11-10 | 2018-02-19 | 28841 |
| PMS-NYSTATIN SUSPENSION 100000 UNIT/ML | 100000UNIT | SUSPENSION | Avoided shortage | 2018-04-20 | 2018-09-19 | 46725 |
| PMS-NYSTATIN SUSPENSION 100000 UNIT/ML | 100000UNIT | SUSPENSION | Resolved | 2019-09-18 | 2020-04-09 | 94269 |
| PMS-NYSTATIN SUSPENSION 100000 UNIT/ML | 100000UNIT | SUSPENSION | Resolved | 2022-10-14 | 2022-11-03 | 171756 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-ZOLEDRONIC ACID | 4MG | SOLUTION | Discontinued | 2017-04-07 | 2017-04-07 | 6094 |
| PMS-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2020-06-15 | 2021-10-27 | 117894 |
| PMS-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2022-07-25 | 2022-07-25 | 165469 |
| PMSC-METFORMIN | 500MG | TABLET | To be discontinued | 2025-01-28 | 2025-01-28 | 248798 |
| PMSC-METFORMIN | 850MG | TABLET | To be discontinued | 2025-01-28 | 2025-01-28 | 248801 |
| SOFLAX SYRUP 4MG/ML | 20MG | SYRUP | Discontinued | 2021-04-23 | 2021-04-23 | 138006 |
| TELMISARTAN | 40MG | TABLET | Discontinued | 2017-12-15 | 2018-02-02 | 33129 |
| TELMISARTAN | 80MG | TABLET | Discontinued | 2018-07-19 | 2021-10-27 | 56080 |
| TELMISARTAN-HCTZ | 25MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25720 |
| TELMISARTAN-HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25724 |
| PMS-DIGOXIN | 0.250MG | TABLET | Discontinued | 2020-02-05 | 2020-02-05 | 105265 |